Dafna Gladman
Affiliations: | Medical Science | University of Toronto, Toronto, ON, Canada |
Area:
Immunology, EpidemiologyGoogle:
"Dafna Gladman"Children
Sign in to add trainee| Lihi Eder | grad student | 2011 | University of Toronto |
| Vinod Chandran | grad student | 2013 | University of Toronto |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Whittall Garcia LP, Gladman DD, Urowitz M, et al. (2021) New EULAR/ACR 2019 SLE Classification Criteria: defining ominosity in SLE. Annals of the Rheumatic Diseases |
| Mai L, Asaduzzaman A, Noamani B, et al. (2021) The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus. Arthritis Research & Therapy. 23: 29 |
| Polachek A, Muntyanu A, Lee KA, et al. (2020) Malignancy in psoriatic disease: Results from prospective longitudinal cohorts. Seminars in Arthritis and Rheumatism. 51: 144-149 |
| Kwok TSH, Sutton M, Yang Ye J, et al. (2020) Prevalence and factors associated with osteoporosis and bone mineral density testing in psoriatic arthritis. Arthritis Care & Research |
| Rahmati S, O'Rielly DD, Li Q, et al. (2020) Rho-GTPase pathways may differentiate treatment response to TNF-alpha and IL-17A inhibitors in psoriatic arthritis. Scientific Reports. 10: 21703 |
| Tselios K, Gladman DD, Taheri C, et al. (2020) Factors Associated with Rapid Progression to End Stage Kidney Disease in Lupus Nephritis. The Journal of Rheumatology |
| Legge A, Kirkland S, Rockwood K, et al. (2020) Prediction of hospitalizations in systemic lupus erythematosus using the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI). Arthritis Care & Research |
| Tselios K, Wakani L, Gladman DD, et al. (2020) Response to placebo in non-renal, non-neuropsychiatric systemic lupus erythematosus: a systematic review and pooled analysis. Rheumatology (Oxford, England) |
| Colaco K, Widdifield J, Luo J, et al. (2020) Trends in Mortality and Cause-specific Mortality among patients with Psoriasis and Psoriatic Arthritis in Ontario, Canada. Journal of the American Academy of Dermatology |
| Coates LC, Merola JF, Mease PJ, et al. (2020) Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology (Oxford, England) |